HSCI Index Rebalance: 35 Adds, 28 Deletes & Changes to Southbound Stock Connect
There are 35 adds & 28 deletes for the HSCI in March leading to 29 adds & 20 deletes for Stock Connect. 19 index constituents could be dropped from...
Luye Pharma Placement (2186.HK) - The Potential Downside to Valuations Is Large
Luye's weak share price is due to poor performance. Without good products, the fundamentals of Luye haven't truly changed. The Placement isn't cost...
China Healthcare Weekly (Jan.13)- Tigermed, HBM, Brii, Jacobio, Dental Implant, Successful Investors
Dental implants VBP results were released-Time to say goodbye to high margins. We analyzed key points of Tigermed/HBM/Brii/Jacobio.Core factors of...
Pre-IPO Shandong Boan Biotechnology - Conservative About the Outlook
Due to lack of differentiated/frontier enough target layout and slow progress, Boan's product commercialization potential is highly uncertain....
No more insights